A large number of clinical trials have shown stem cell therapy to be a promising therapeutic
approach for the treatment of cardiovascular diseases. Since the first transplantation into …

Experimental and early clinical data suggest that, due to several unique properties,
mesenchymal stem cells (MSCs) may be more effective than other cell types for diseases …

The stem cell field is hindered by its inability to noninvasively monitor transplanted cells
within the target organ in a repeatable, time-sensitive, and condition-specific manner. We …

Aim: To evaluate the feasibility and safety of a novel myocardial regeneration strategy using
human WJMSCs as a unique, allogenic but immuno-privileged, off-the-shelf cellular …

Background CD34+ cells have been used to treat the patients with heart failure, but the
outcome is variable. It is of great significance to scrutinize the fate and the mechanism of …

Rationale: New therapies for refractory angina are needed. Objective: Assessment of
transendocardial delivery of bone marrow CD133+ cells in patients with refractory angina …

Stromal vascular fraction (SVF) cells are used clinically for various therapeutic targets. The
location and persistence of engrafted SVF cells are important parameters for determining …

Aims Circulating angiogenic cells (CACs) promote revascularization of ischaemic tissues
although their underlying mechanism of action and the consequences of delivering varying …

The human umbilical cord has recently emerged as an attractive potential source of
mesenchymal stromal cells (MSCs) to be adopted for use in regenerative medicine …

Objective Abdominal aortic aneurysm (AAA) is a frequent, potentially life-threatening,
disease that can only be treated by surgical means such as open surgery or endovascular …